Towards quality assurance and quality control in untargeted metabolomics studies

Richard D. Beger(National Center for Toxicological Research), Krista A. Zanetti(National Institutes of Health), Ioanna Ntai(Thermo Fisher Scientific (United States)), David Broadhurst(Edith Cowan University), Baljit K. Ubhi, Katrice A. Lippa(National Institute of Standards and Technology), Keren L. Witkin(National Cancer Institute), Daniel Raftery(University of Washington), Thomas J. Flynn(United States Food and Drug Administration), Anne M. Evans(Metabolon (United States)), Jonathan D. Mosley(Environmental Protection Agency), Ping-Ching Hsu(University of Arkansas for Medical Sciences), Daniel Shaughnessy(National Institute of Environmental Health Sciences), Clary B. Clish(Broad Institute), Daniel W. Bearden(National Institute of Standards and Technology), Ian D. Wilson(Imperial College London), Timothy Spaeder(Triangle), Richard M. Higashi(University of Louisville Hospital), Surendra Dasari(Mayo Clinic in Arizona), Maureen Kachman(University of Michigan), Claire O’Donovan(European Bioinformatics Institute), B A Spalholz(National Cancer Institute), David M. Herrington(University of Washington), Bianca Bethan, Leslie Derr(National Institutes of Health), Abbas Bandukwala(United States Food and Drug Administration), Padma Maruvada(National Institutes of Health), Tilman Walk, Fariba Tayyari(University of Georgia), Warwick B. Dunn(University of Birmingham), Thomas Härtung(Johns Hopkins University), Helen Karuso(Biocrates Life Sciences (Austria)), Mukesh Verma(National Cancer Institute), Christina M. Jones(National Institute of Standards and Technology), Amanda Souza(Dana-Farber Cancer Institute), Gary Kruppa(Bruker (United States)), Steve Fischer(Center for Infectious Disease Research), Mary C. Playdon(University of Utah)
Metabolomics
January 1, 2019
Cited by 149


Related Papers